UnitedHealth (UNH) Reports Q4 Earnings: What Key Metrics Have to Say

Zacks
16 Jan

UnitedHealth Group (UNH) reported $100.81 billion in revenue for the quarter ended December 2024, representing a year-over-year increase of 6.8%. EPS of $6.81 for the same period compares to $6.16 a year ago.

The reported revenue compares to the Zacks Consensus Estimate of $102.25 billion, representing a surprise of -1.41%. The company delivered an EPS surprise of +1.49%, with the consensus EPS estimate being $6.71.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how UnitedHealth performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

  • UnitedHealthcare Customer Profile - People Served - Total UnitedHealthcare - Medical: 50.68 million compared to the 50.36 million average estimate based on five analysts.
  • UnitedHealthcare Customer Profile - People Served - Total Commercial - Domestic: 29.73 million versus 29.7 million estimated by five analysts on average.
  • UnitedHealthcare Customer Profile - People Served - Commercial - Domestic- Risk-based: 8.85 million versus the five-analyst average estimate of 8.87 million.
  • UnitedHealthcare Customer Profile - People Served - Commercial - Domestic- Fee-based: 20.89 million versus 20.83 million estimated by five analysts on average.
  • Revenues- Investment and other income: $1.55 billion versus $1.21 billion estimated by 10 analysts on average. Compared to the year-ago quarter, this number represents a +31.6% change.
  • Revenues- Products: $13.48 billion compared to the $13.04 billion average estimate based on 10 analysts. The reported number represents a change of +19.1% year over year.
  • Revenues- Services: $9.30 billion versus $9.37 billion estimated by 10 analysts on average. Compared to the year-ago quarter, this number represents a +6.8% change.
  • Revenues- Premiums: $76.48 billion compared to the $78.16 billion average estimate based on 10 analysts. The reported number represents a change of +4.5% year over year.
  • Revenues- Optum Insight: $4.78 billion compared to the $5.10 billion average estimate based on six analysts. The reported number represents a change of -0.1% year over year.
  • Revenues- Optum Rx: $35.77 billion versus $35.34 billion estimated by six analysts on average. Compared to the year-ago quarter, this number represents a +14.8% change.
  • Revenues- Optum Health: $25.66 billion versus $27.28 billion estimated by six analysts on average. Compared to the year-ago quarter, this number represents a +4.6% change.
  • Revenues- UnitedHealthcare- Total: $74.13 billion compared to the $75.52 billion average estimate based on six analysts. The reported number represents a change of +4.7% year over year.
View all Key Company Metrics for UnitedHealth here>>>

Shares of UnitedHealth have returned +8.7% over the past month versus the Zacks S&P 500 composite's -1.6% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

UnitedHealth Group Incorporated (UNH) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10